Mark E. Tryniski, Director at CONMED CORP (CNMD), bought 2,000 shares at $11.74 ($23K) on 2009-03-06, disclosed to the SEC on 2009-03-06.
Open-market purchase of $23k CNMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CNMD | SELL | 2021-11-08 | $3.9M | — | Filing → |
| CNMD | SELL | 2021-02-23 | $427K | — | Filing → |
| CNMD | SELL | 2021-02-18 | $1.2M | — | Filing → |